Magazine Article | August 23, 2018

Democrats And Trump Focus On Pharmaceutical Pricing

Source: Life Science Leader

By John McManus, The McManus Group

“There is no terror in the bang, only in the anticipation of it.” – Alfred Hitchcock

As the midterm elections approach, with the trajectory pointing toward increasing likelihood of the Democrats taking control of the House of Representatives and with each Trump tweet on drug pricing, a feeling of foreboding has settled over the pharmaceutical industry.

House Democrats have chosen drug pricing as one of the few substantive issues to campaign on, believing that their energized but fractured based needs little other motivation to recapture a key branch of government. In the August recess packet Democrat Leader Nancy Pelosi (D-CA) sent home with her members, point one said: “Our closing argument: For the People” is lowering your health costs and prescription drug prices.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: